Video

Andrew Hershey, MD, PhD

Publish date: June 28, 2016

Dr. Hershey discusses the Childhood and Adolescent Migraine Prevention (CHAMP) study, a comparative effectiveness study of amitriptyline, topiramate, and placebo.

 

References

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

Lars Edvinsson, MD
MDedge Neurology
AAN Updates Guidelines on Use of Botulinum Toxin for Four Disorders
MDedge Neurology
What Distinguishes Chronic Migraine From Episodic Migraine?
MDedge Neurology
Self-Administered Tool Identifies Chronic Migraine
MDedge Neurology
Migraine Treatments Previously Deemed Safe During Pregnancy Could Pose Serious Risks
MDedge Neurology
The New Face of Personalized Medicine in Headache Therapy
MDedge Neurology
What Is the Best Migraine Prevention Therapy?
MDedge Neurology
Emotional Abuse in Childhood May Be Linked to Migraine in Adulthood
MDedge Neurology
Jack Gladstein, MD
MDedge Neurology
K. Ravishankar, MD
MDedge Neurology

Related Articles